Your browser doesn't support javascript.
loading
Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
Huang, Weiwei; Wang, Chenxi; Shen, Yangkun; Chen, Qi; Huang, Zhijian; Liu, Jian; Lin, Xiaoyan; Wang, Lili; Wu, Fan; Chen, Xinhua; Li, Nani; Hong, Yi; Chen, Mulan; Li, Jieyu; Huang, Chuanzhong.
Afiliação
  • Huang W; Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, 350001, Fuzhou, Fujian province, China.
  • Wang C; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Shen Y; Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Chen Q; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, 350117, College Town, Fuzhou, Fujian Province, PR China.
  • Huang Z; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, 350117, College Town, Fuzhou, Fujian Province, PR China.
  • Liu J; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, 350117, College Town, Fuzhou, Fujian Province, PR China.
  • Lin X; Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Wang L; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Wu F; Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, 350001, Fuzhou, Fujian province, China. 0591linxiaoyan@sina.com.
  • Chen X; Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China. 0591linxiaoyan@sina.com.
  • Li N; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Hong Y; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Chen M; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Li J; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
  • Huang C; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
BMC Cancer ; 24(1): 378, 2024 Mar 25.
Article em En | MEDLINE | ID: mdl-38528446
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article